Explore Business Standard
India and the US have a "huge potential" for collaboration in healthcare across segments such as AI and technology, drug development and medical hardware, world-renowned cardiovascular and cardiothoracic surgeon Dr Naresh Trehan said. "We are now in a stage where I think the time has come... It's India's time. I'm gung-ho myself, I would say that anybody... looking at India should move, don't waste anymore time because the opportunities are huge," Trehan, Chairman and Managing Director of Medanta and a Padma Bhushan awardee, said during a conversation here last week. The event was hosted by the Consulate General of India in New York here last week titled 'Healthcare in a Developed India 2047'. The Consulate said that the key highlights of the event included a vision to make high quality healthcare universally accessible and affordable; India's rising corps of highly trained medical and allied-health professionals. Strong emphasis on pharma innovation and research; transformative ro
Healthcare industry body NATHEALTH has asked the government to increase public spending on healthcare to over 2.5 per cent of GDP with urgent action to tackle non-communicable diseases, including tax deductions of up to Rs 10,000 on individuals for preventive health check-ups. In its pre-Budget recommendations to the government, NATHEALTH said it outlined a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage. The recommendations call for a balanced mix of fiscal support, structural reforms, and public-private collaboration to build a robust, future-ready health system, it said in a statement. In its recommendations, NATHEALTH asked the sector to be declared 'core infrastructure' and create a healthcare infrastructure fund of Rs 50,000 crore, saying currently there is limited access to long-term, lower-cost capital for hospitals and diagnostic networks. New projects have long gestational periods requiring flexible mid-term ...
Eureka Forbes Ltd, a health and hygiene product maker, on Thursday reported an increase of 31.77 per cent in its consolidated net profit to Rs 62.92 crore in the September quarter of FY26. The company had a net profit of Rs 47.74 crore in the July-September quarter a year ago, according to a regulatory filing by the firm, now controlled by private equity firm Advent International. Revenue from operations was up 14.7 per cent to Rs 772.07 crore during the September quarter of FY26. It stood at Rs 673.13 crore in the corresponding quarter a year ago. This is the "eighth successive quarter of double digit growth", said Eureka Forbes in its earnings presentation. Eureka Forbes' total expenses increased 12.55 per cent to Rs 693.0 crore in the September quarter on a year-on-year basis. Commenting on the results MD and CEO Pratik Pota said: "In an uncertain and evolving external environment, Q2 FY26 was an exciting milestone quarter for us. We delivered a strong revenue growth of 14.9 pe